Compare iShares MSCI Japan ETF (EWJ) vs FMC Corp (FMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Japan ETF vs FMC Corp — how do they compare? iShares MSCI Japan ETF trades at $97.82 (market cap $23.87B), while FMC Corp trades at $8.3 (market cap $1.39B). The key difference: iShares MSCI Japan ETF is far larger — about 17.2× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while iShares MSCI Japan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and FMC Corp for 68 Days on average.
| EWJ | FMC | |
|---|---|---|
Market Cap | $23.87B | $1.39B |
Volume | 5,412,820 | 4,145,979 |
Sector | Broad Market / Factor | Basic Materials |
52-Week High | $99.32 | $30.63 |
52-Week Low | $78.36 | $8.44 |
Typical Hold Time | 56 Days | 68 Days |
Enterprise Value | — | $5.19B |
Dividend Yield | — | 3.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.76, down 0.57% on the day amid mixed technical signals with a neutral overall rating. The ETF faces headwinds from Japan's monetary policy uncertainty as the Bank of Japan continues its tightening cycle, while benefiting from international equity outperformance trends in 2026. Technical indicators show the ETF trading near pivot point resistance at $98 with support at $97.
The outlook remains balanced with potential upside from Japan's AI and semiconductor exposure offset by currency volatility and rising bond yields. Key risks include yen fluctuations and global rate pressures, while institutional interest in Japanese equities provides support. The ETF's performance will hinge on BOJ policy effectiveness and sustained international market strength.
FMC trades at $8.36, down 8.03% in the past 24 hours, reflecting bearish technical signals and weak profitability. The company reported a net loss of -$2.24B in 2025, with negative margins and declining revenue. Recent news includes a regulatory filing for rimisoxafen in Brazil and a minority equity investment by Tessenderlo Group. Cash flow trends show volatility, with 2025 net cash flow positive at $227M but driven by financing activities.
The outlook remains challenging due to persistent losses and high debt, though analyst consensus suggests upside with a $14.60 price target. Key risks include execution on deleveraging, cyclical industry pressures, and competitive threats. Investment opportunity hinges on successful turnaround efforts and new product approvals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Japan ETF
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →
